Suggestions
Kristin Pothier
Global Healthcare and Life Sciences Deal Advisory and Strategy Leader, KPMG
Kristin Pothier is a renowned figure in the healthcare and life sciences industry, currently serving as the national and global HCLS strategy leader at KPMG, with an additional role as the global healthcare and life sciences deal advisory leader.
With an extensive background spanning over 25 years in research, strategy consulting, and M&A diligence within medical innovation, Kristin specializes in deal advisory and corporate strategy for pharmaceutical, diagnostics, and consumer health companies, investors, and medical institutions worldwide.
Kristin is a distinguished speaker, workshop leader, and writer in the life sciences sector, focusing on clinical laboratory and medical innovation. She has operational experience and has executed global deals across various regions worldwide.
Her impactful book, 'Personalizing Precision Medicine', has been widely acclaimed for its comprehensive insights into diagnostics and global precision medicine, establishing her as an authority in the field.
In addition to her corporate roles, Kristin collaborates with health systems and related organizations on innovative services strategies, diligences, and operations, contributing to areas such as clinical laboratory builds, health IT, and hospital services.
Kristin's background includes serving in key positions at reputable organizations such as KPMG, EY, DxInsights, and Health Advances, as well as having a significant scientific and clinical diagnostics development background at Genome Therapeutics and Genzyme/Sanofi.
She holds a Bachelor's degree in Biochemistry from Smith College and pursued postgraduate studies in clinical epidemiology, health management, and maternal and child health at the Harvard T.H. Chan School of Public Health.
Highlights
Stay in your sweats and put your feet up! Our Virtual Global Life Sciences Summit is a premier event for all of you life sciences executives on our hottest topics and global trends. This yearly summit brings together industry leaders, experts, and innovators to share insights on the opportunities and challenges impacting our dynamic industry. We look forward to having you join us! #KPMGLifeSciences
The J.P. Morgan Healthcare Conference (#JPMHC24) is right around the corner, and I couldn’t be more excited to be on the ground participating in meaningful conversations that will help shape the future of the industry. On January 9th, I have the pleasure of moderating a discussion centered around #innovation and AI in #healthcare where I’ll be accompanied by Leigh Anderson – Chief Operating officer at Premier Inc., Hannah Koczka – VP at Northwestern Medicine, and my colleague and KPMG US National Healthcare Sector Leader Ashraf (Ash) Shehata. The following day, I have the good fortune of co-leading the Goodwin-KPMG Life Sciences Day and leading a panel that zeroes in on AI’s role in precision medicine where I’ll be offering my perspective alongside Yusuf Henriques – CEO of IndyGeneUS AI | Google for Startups ’23, and Bonnie Anderson – CEO of PinkDx, Inc.. In addition to my involvement at the conference, I’m eager to share that next week on 1/8, KPMG US will be releasing its 2024 Healthcare & Life Sciences Investment Outlook report that provides insight into where healthcare and life sciences investors are looking to allocate their capital.
For those of you coming from the Northeast braving the elements to get to JPM, we can do it! It's just a little snow/sleet/ice! See you soon!
